Eric I. Richman
2021 - Gain Therapeutics
In 2021, Eric I. Richman earned a total compensation of $600.2K as Chief Executive Officer at Gain Therapeutics, a 117% increase compared to previous year.
Compensation breakdown
| Bonus | $80,000 |
|---|---|
| Non-Equity Incentive Plan | $120,000 |
| Salary | $373,458 |
| Other | $26,707 |
| Total | $600,165 |
Richman received $373.5K in salary, accounting for 62% of the total pay in 2021.
Richman also received $80K in bonus, $120K in non-equity incentive plan and $26.7K in other compensation.
Rankings
In 2021, Eric I. Richman's compensation ranked 10,320th out of 12,415 executives tracked by ExecPay. In other words, Richman earned more than 16.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,320 out of 12,415 | 17th |
Division Manufacturing | 4,571 out of 5,505 | 17th |
Major group Chemicals And Allied Products | 2,044 out of 2,375 | 14th |
Industry group Drugs | 1,813 out of 2,096 | 14th |
Industry Pharmaceutical Preparations | 1,345 out of 1,546 | 13th |
Source: SEC filing on May 13, 2022.
Richman's colleagues
We found two more compensation records of executives who worked with Eric I. Richman at Gain Therapeutics in 2021.